Trial intelligence / Profile preview

Methotrexate for Prevention of Postmolar Gestational Trophoblastic Disease

NCT01984099Phase 3Completed

Sponsor
University of the Philippines
Start
Dec 2011
Primary completion
Aug 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methotrexate in gestational trophoblastic disease (GTD), sponsored by University of the Philippines. Started Dec 2011; status: completed.

02

Drugs

methotrexate
03

Conditions

gestational trophoblastic disease (GTD)

Beyond the preview

Go deeper on NCT01984099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01984099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call